M. Kitamura et al.
Bull. Chem. Soc. Jpn. Vol. 79, No. 10 (2006) 1557
dried over anhydrous Na2SO4, filtered, and evaporated. Purifica-
tion by column chromatography (SiO2) gave 10a (1.78 g, 93%)
as pale yellow crystals.
ature and stirred for 3 h. The reaction was quenched with aq
NaHCO3, and the mixture was extracted with CH2Cl2. The com-
bined organic extracts were washed with brine, dried over anhy-
drous Na2SO4 and concentrated in vacuo. The residue was puri-
fied by column chromatography (SiO2; hexane:acetone = 2:1)
to afford enecarbamate 12 (129 mg, 75%) as a colorless oil. Com-
pound 12 was also prepared from imine 10b in a similar manner as
10a, in 73%.
Mp 71–72 ꢂC (hexane–Et2O); IR (KBr) 1626, 1377, 1136,
1022, 964, 879, 742 cmꢃ1 1H NMR (500 MHz, CDCl3) ꢁ 1.33
;
(1H, ddd, J ¼ 0:8, 1.8, 13.5 Hz), 1.65 (1H, dd, J ¼ 1:2, 12.5 Hz),
1.84–1.96 (3H, m), 2.05 (1H, ddddd, J ¼ 4:9, 4.9, 12.6, 12.6,
13.5 Hz), 2.34–2.59 (2H, m), 2.65 (1H, dd, J ¼ 4:6, 9.5 Hz),
3.14 (1H, s), 3.75 (2H, ddd, J ¼ 1:8, 10.9, 12.6 Hz), 4.08 (2H,
ddd, J ¼ 0:8, 4.9, 10.9 Hz), 4.17 (1H, d, J ¼ 4:5 Hz), 4.59 (1H,
dd, J ¼ 4:8, 4.8 Hz), 4.64 (1H, d, J ¼ 5:1 Hz), 5.42 (1H, dd,
J ¼ 4:6, 5.1 Hz), 7.25–7.30 (3H, m), 7.51–7.55 (2H, m); 13C NMR
(125 MHz, CDCl3) ꢁ 25.7, 28.4, 30.8, 36.7, 46.7, 49.5, 66.8, 66.8,
76.7, 84.0, 89.5, 101.1, 127.3, 129.2, 129.9, 133.4, 185.8; Anal.
Found: C, 58.11; H, 5.87; N, 3.57%. Calcd for C19H23NO3Se:
C, 58.16; H, 5.91; N, 3.57%.
IR (neat) 3435, 1711, 1402, 1333, 1277, 1240, 1138, 1014
1
cmꢃ1; H NMR (500 MHz, CDCl3) ꢁ 1.29 (1H, d, J ¼ 13:4 Hz),
1.98–2.08 (1H, m), 2.16–2.20 (1H, m), 2.18 (1H, d, J ¼ 18:6 Hz),
2.24–2.34 (2H, m), 2.49 (1H, dd, J ¼ 4:5, 18.6 Hz), 3.04 (1H, br),
3.71 (2H, dt, J ¼ 2:3, 12.1 Hz), 4.03–4.06 (2H, m), 4.22–4.26
(2H, m), 4.50 (1H, t, J ¼ 5:3 Hz), 4.58 (2H, br), 5.18 (1H, d,
J ¼ 10:4 Hz), 5.27 (1H, d, J ¼ 17:2 Hz), 5.85–5.94 (3H, m), 6.04
(1H, br); 13C NMR (125 MHz, CDCl3) ꢁ 25.7, 28.4, 35.1, 38.9,
54.9, 65.7, 66.9, 67.9, 101.9, 102.9, 117.5, 125.4, 131.7, 132.6,
142.3, 152.0; Anal. Found: C, 63.35; H, 7.38; N, 4.08%. Calcd
for C17H23NO5: C, 63.54; H, 7.21; N, 4.36%.
2-Bromo-5-[2-(1,3-dioxan-2-yl)ethyl]-8-oxa-4-azatricyclo-
[4.2.1.03;7]non-4-ene (10b). To a solution of O-pentafluoroben-
zoyloxime 9c (145 mg, 0.324 mmol) and lithium bromide (110
mg, 1.27 mmol) in 1,4-dioxane (7 mL) at room temperature was
6-Benzyloxycarbonyl-7-[2-(1,3-dioxan-2-yl)ethylidene]-6-aza-
bicyclo[3.2.1]oct-3-en-8-ol (13). IR (neat) 3413, 1711, 1664,
1402, 1277, 1136, 1014 cmꢃ1; 1H NMR (500 MHz, CDCl3) ꢁ 1.29
(1H, ddd, J ¼ 0:6, 2.3, 13.5 Hz), 1.94–2.09 (2H, m), 2.20 (1H, d,
J ¼ 18:8 Hz), 2.25–2.35 (2H, m), 2.50 (1H, dd, J ¼ 4:6, 18.8 Hz),
3.05 (1H, m), 3.71 (2H, ddd, J ¼ 2:3, 12.1, 11.7 Hz), 4.06 (2H,
ddd, J ¼ 0:6, 4.4, 11.7 Hz), 4.23–4.27 (1H, m), 4.29 (1H, br),
4.50 (1H, br), 5.13 (2H, br), 5.94 (1H, br), 6.08 (1H, br), 7.27–
7.37 (5H, m).
added CuBr SMe2 (66.2 mg, 0.322 mmol). After the reaction mix-
ꢁ
ture was stirred for 2 h at room temperature, brine and N,N,N0,N0-
tetramethylethylenediamine was added. The mixture was extract-
ed with EtOAc, and the combined organic extracts were washed
with brine, dried over anhydrous MgSO4, filtered, and evaporated.
The residue was purified by column chromatography (florisil;
hexane:acetone = 4:1) to give 10b (100 mg, 98%, exo:endo =
1:2.2) as a colorless oil. O-Methoxycarbonyloxime 9b also gave
10b in 65% (exo:endo = 1:3 mixture) in a similar manner as 9c.
exo Isomer: IR (neat) 2964, 2852, 1699, 1622, 1377, 1144, 1082,
6-Benzyloxycarbonyl-7-[endo-2-(1,3-dioxan-2-yl)ethyl]-6-aza-
bicyclo[3.2.1]oct-3-en-8-ol (endo-14). IR (neat) 3417, 1693,
;
1415, 1136, 1088 cmꢃ1 1H NMR (500 MHz, CDCl3, 323 K) ꢁ
1043, 1001, 883, 850, 793 cmꢃ1
;
1H NMR (500 MHz, CDCl3) ꢁ
1.32 (1H, dd, J ¼ 1:0, 13.5 Hz), 1.67 (1H, d, J ¼ 12:6 Hz), 1.83–
1.91 (3H, m), 1.98–2.14 (1H, m), 2.37–2.48 (2H, m), 2.63 (1H, dd,
J ¼ 4:6, 9.9 Hz), 3.67 (1H, s), 3.72 (2H, dd, J ¼ 11:9, 13.5 Hz),
4.06 (2H, brd, J ¼ 11:9 Hz), 4.36 (1H, d, J ¼ 4:5 Hz), 4.57 (1H,
t, J ¼ 4:8 Hz), 4.73 (1H, d, J ¼ 5:2 Hz), 5.42 (1H, dd, J ¼ 4:5,
4.6 Hz); 13C NMR (125 MHz, CDCl3) ꢁ 25.7, 28.3, 30.5, 36.5,
46.2, 51.9, 66.8, 66.84, 79.4, 86.1, 89.1, 101.0, 186.8; HRMS
(FABþ) Found: m=z 316.0530, Calcd for C13H19BrNO3: ðM þ
HÞþ, 316.0548.
1.28 (1H, d, J ¼ 13:3 Hz), 1.47–1.52 (3H, br), 1.90 (1H, br d, J ¼
9:0 Hz), 2.03 (1H, ddddd, J ¼ 4:8, 4.8, 12.6, 12.6, 13.3 Hz), 2.25
(1H, br d, J ¼ 18:4 Hz), 2.39–2.43 (3H, br m), 3.69 (2H, br), 3.88
(1H, br), 4.04 (2H, dd, J ¼ 4:8, 10.8 Hz), 4.13 (1H, ddd, J ¼ 4:5,
4.5, 9.0 Hz), 4.21 (1H, br), 4.47 (1H, br), 5.07 (1H, d, J ¼ 12:4
Hz), 5.12 (1H, d, J ¼ 12:4 Hz), 5.89–5.93 (1H, br m), 7.26–7.33
(5H, m).
6-t-Butoxycarbonyl-7-[2-(1,3-dioxan-2-yl)ethylidene)-6-aza-
bicyclo[3.2.1]oct-3-en-8-ol (15). IR (neat) 3442, 1707, 1390,
1
endo Isomer: IR (neat) 2962, 2852, 1699, 1628, 1442, 1377,
1242, 1144, 1028, 1001, 955, 874, 777 cmꢃ1; 1H NMR (500 MHz,
C6D6) ꢁ 0.62 (1H, brd, J ¼ 13:2 Hz), 1.65 (1H, ddd, J ¼ 4:5, 9.2,
10.4 Hz), 1.73–1.84 (1H, m), 1.88 (1H, dd, J ¼ 1:6, 9.2 Hz), 1.94
(1H, dd, J ¼ 4:9, 10.4 Hz), 2.09–2.17 (1H, m), 2.20–2.26 (1H,
m), 2.28–2.35 (1H, m), 2.43–2.49 (1H, m), 3.34–3.42 (2H, m),
3.67–3.83 (4H, m), 4.10 (1H, dd, J ¼ 4:5, 4.5 Hz), 4.69 (1H, t,
J ¼ 5:0 Hz), 4.79 (1H, dd, J ¼ 4:6, 4.9 Hz); 13C NMR (125 MHz,
C6D6) ꢁ 25.7, 28.5, 30.2, 30.6, 47.9, 48.6, 66.8, 66.9, 82.0, 90.3,
100.9, 186.8; HRMS (FABþ) Found: m=z 316.0533, Calcd for
C13H19BrNO3: ðM þ HÞþ, 316.0548.
1138, 669 cmꢃ1; H NMR (500 MHz, CDCl3) ꢁ 1.30 (1H, d, J ¼
13:4 Hz), 1.46 (9H, s), 1.92 (1H, d, J ¼ 10:0 Hz), 2.05 (1H, ddddd,
J ¼ 4:1, 4.1, 12.7, 12.7, 13.4 Hz), 2.19 (1H, d, J ¼ 18:7 Hz),
2.25–2.35 (2H, m), 3.04 (1H, br), 3.72 (2H, ddd, J ¼ 1:8, 11.4,
12.7 Hz), 4.06 (2H, dd, J ¼ 4:1, 11.4 Hz), 4.19 (1H, br), 4.23 (1H,
br quin), 4.52 (1H, dd, J ¼ 5:3, 5.3 Hz), 5.94 (3H, br).
6-t-Butoxycarbonyl-7-[2-(1,3-dioxan-2-yl)ethylidene]-6-aza-
bicyclo[3.2.1]oct-3-ene-8-one (16). IR (neat) 1782, 1711, 1383,
1136, 1014, 862 cmꢃ1; 1H NMR (500 MHz, CDCl3) ꢁ 1.29 (1H, d,
J ¼ 13:4 Hz), 1.46 (9H, s), 2.02 (1H, ddddd, J ¼ 4:7, 4.7, 12.7,
12.7, 13.4 Hz), 2.25 (2H, dd, J ¼ 5:2, 7.7 Hz), 2.84 (1H, d, J ¼
17:6 Hz), 2.92 (1H, dddd, J ¼ 2:3, 3.2, 4.6, 17.6 Hz), 3.31 (1H,
br), 3.71 (2H, dddd, J ¼ 2:6, 2.6, 11.1, 12.7 Hz), 4.04 (2H, dd,
J ¼ 4:7, 11.1 Hz), 4.18 (1H, br), 4.51 (1H, dd, J ¼ 5:2, 5.2 Hz),
5.78 (1H, ddd, J ¼ 3:2, 3.2, 8.9 Hz), 6.13 (2H, br); 13C NMR
(125 MHz, CDCl3) ꢁ 25.7, 28.3, 35.0, 39.9, 47.3, 58.9, 66.9,
81.3, 101.6, 102.8, 130.8, 131.1, 139.2, 151.3, 206.5.
6-Allyloxycarbonyl-7-[2-(1,3-dioxan-2-yl)ethylidene]-6-aza-
bicyclo[3.2.1]oct-3-ene-8-ol (12). To a solution of the selenide
10a (211 mg, 0.537 mmol) in THF (8 mL) at ꢃ78 ꢂC was slowly
added lithium naphthalenide (0.1 M solution in THF, 3 mL, 1.5
mmol). The mixture was stirred for 25 min at ꢃ78 ꢂC, and the re-
action was quenched with MeOH. The mixture was evaporated,
and the residue was diluted in CH2Cl2 (8 mL). The resulting sus-
pension was filtered through a celite pad and the filtrate was
evaporated. To a solution of the residue in CH2Cl2 (8 mL) at
ꢃ20 ꢂC was added pyridine (0.057 mL, 7.1 mmol) and AllocCl
(0.063 mL, 6.0 mmol). The mixture was warmed to room temper-
6-Allyloxycarbonyl-7-[2-(1,3-dioxan-2-yl)ethylidene]-6-aza-
bicyclo[3.2.1]oct-3-ene-8-one (17). To a solution of enecarba-
mate 12 (95.2 mg, 0.296 mmol) in CH2Cl2 (1 mL) and DMSO
(1 mL) was added triethylamine (195 mg, 1.93 mmol), a solution
of SO3 pyridine (142 mg, 0.888 mmol) in DMSO (1 mL) and
ꢁ